DK1410793T3 - Administreringsform af ibuprofen-natrium - Google Patents

Administreringsform af ibuprofen-natrium

Info

Publication number
DK1410793T3
DK1410793T3 DK03405225T DK03405225T DK1410793T3 DK 1410793 T3 DK1410793 T3 DK 1410793T3 DK 03405225 T DK03405225 T DK 03405225T DK 03405225 T DK03405225 T DK 03405225T DK 1410793 T3 DK1410793 T3 DK 1410793T3
Authority
DK
Denmark
Prior art keywords
administration
ibuprofen sodium
ibuprofen
sodium
Prior art date
Application number
DK03405225T
Other languages
English (en)
Inventor
Peter Dr Gruber
Markus Dr Reher
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28796671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1410793(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Application granted granted Critical
Publication of DK1410793T3 publication Critical patent/DK1410793T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03405225T 2002-10-14 2003-04-03 Administreringsform af ibuprofen-natrium DK1410793T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01703/02A CH693586A8 (de) 2002-10-14 2002-10-14 Darreichungsform von Ibuprofen-Natrium.

Publications (1)

Publication Number Publication Date
DK1410793T3 true DK1410793T3 (da) 2006-04-03

Family

ID=28796671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03405225T DK1410793T3 (da) 2002-10-14 2003-04-03 Administreringsform af ibuprofen-natrium

Country Status (32)

Country Link
US (1) US20040102522A1 (da)
EP (1) EP1410793B1 (da)
JP (1) JP4608316B2 (da)
KR (1) KR101046894B1 (da)
CN (1) CN100592909C (da)
AR (1) AR041428A1 (da)
AT (1) ATE309789T1 (da)
AU (1) AU2003266094B2 (da)
BR (1) BRPI0315248B1 (da)
CA (1) CA2500987A1 (da)
CH (1) CH693586A8 (da)
CO (1) CO5700709A2 (da)
DE (1) DE50301661D1 (da)
DK (1) DK1410793T3 (da)
EA (1) EA007914B1 (da)
EC (1) ECSP055793A (da)
ES (1) ES2249702T3 (da)
HR (1) HRP20050429A2 (da)
IL (1) IL167357A (da)
MA (1) MA27490A1 (da)
MX (1) MXPA05003592A (da)
MY (1) MY132858A (da)
NO (1) NO20052343L (da)
NZ (1) NZ539405A (da)
PA (1) PA8586101A1 (da)
PE (1) PE20040417A1 (da)
PL (1) PL376177A1 (da)
SI (1) SI1410793T1 (da)
TW (1) TWI262800B (da)
UA (1) UA86751C2 (da)
WO (1) WO2004035024A1 (da)
ZA (1) ZA200502925B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3920358A1 (de) * 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20050176809A1 (en) * 2004-02-05 2005-08-11 Rodlen Laboratories, Inc. Method and compositions for treatment of painful disorders
WO2006016126A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising paracetamol a nsaid and a sugar alcohol made by melt extrusion
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
WO2006093353A1 (ja) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited 放出制御組成物
EP2559430B1 (en) 2005-03-22 2015-06-24 Losan Pharma GmbH Solubilized Ibuprofen
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
DE102006029233A1 (de) * 2006-06-26 2007-12-27 Liedtke, Rainer K., Dr. Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika
CL2007002425A1 (es) 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
EP2309988B1 (en) * 2008-07-21 2015-11-25 SI Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
ES2654331T3 (es) * 2009-06-22 2018-02-13 Wyeth Llc Comprimidos de ibuprofeno de sodio y procedimientos de fabricación de composiciones farmacéuticas que incluyen ibuprofeno de sodio
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
US20180078516A1 (en) * 2016-09-19 2018-03-22 Innovazone Labs LLC Pharmaceutical Composition of Ibuprofen Sodium for Oral Administration
CN113893227B (zh) * 2021-11-18 2023-04-14 山东则正医药技术有限公司 布洛芬片的制备原料、制备方法和布洛芬片
CN119488489A (zh) * 2024-11-29 2025-02-21 华中药业股份有限公司 一种布洛芬片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
US5104648A (en) * 1989-02-02 1992-04-14 Mallinckrodt Specialty Chemicals Company High ibuprofen content granulations
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US6083430A (en) * 1994-10-28 2000-07-04 Fuisz Technologies Ltd. Method of preparing a dosage unit by direct tableting and product therefrom
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica

Also Published As

Publication number Publication date
CA2500987A1 (en) 2004-04-29
PA8586101A1 (es) 2005-05-10
CH693586A8 (de) 2003-12-15
PE20040417A1 (es) 2004-07-14
JP4608316B2 (ja) 2011-01-12
TW200407175A (en) 2004-05-16
BRPI0315248B1 (pt) 2016-08-02
ES2249702T3 (es) 2006-04-01
KR101046894B1 (ko) 2011-07-06
ZA200502925B (en) 2006-02-22
AU2003266094B2 (en) 2009-04-23
CN100592909C (zh) 2010-03-03
CH693586A5 (de) 2003-10-31
WO2004035024A1 (en) 2004-04-29
US20040102522A1 (en) 2004-05-27
ATE309789T1 (de) 2005-12-15
UA86751C2 (ru) 2009-05-25
EA007914B1 (ru) 2007-02-27
EP1410793B1 (de) 2005-11-16
NO20052343L (no) 2005-06-02
DE50301661D1 (de) 2005-12-22
AU2003266094A1 (en) 2004-05-04
ECSP055793A (es) 2005-08-11
CO5700709A2 (es) 2006-11-30
EP1410793A1 (de) 2004-04-21
MY132858A (en) 2007-10-31
SI1410793T1 (sl) 2006-04-30
PL376177A1 (en) 2005-12-27
MA27490A1 (fr) 2005-08-01
NZ539405A (en) 2006-12-22
IL167357A (en) 2009-05-04
HRP20050429A2 (en) 2005-06-30
JP2006505558A (ja) 2006-02-16
EA200500649A1 (ru) 2005-10-27
CN1705470A (zh) 2005-12-07
MXPA05003592A (es) 2005-09-30
KR20050083760A (ko) 2005-08-26
TWI262800B (en) 2006-10-01
BR0315248A (pt) 2005-08-23
AR041428A1 (es) 2005-05-18

Similar Documents

Publication Publication Date Title
DK1410793T3 (da) Administreringsform af ibuprofen-natrium
DE60328925D1 (de) Jittergenerator
PT1501534E (pt) Formulacoes farmaceuticas
DK1438306T3 (da) Derivater af UK-2A
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
IS7714A (is) Lyfjasamsetningar úr módafíníl
ATE380544T1 (de) Umhüllte feste darreichungsform
DE60309642D1 (de) Abgedichtete Muffe
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan
DE60312848D1 (de) Verbindungsanschluss
CY2017048I2 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
DK1540907T3 (da) Konferencesystem
CY2018005I1 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DE60319997D1 (de) Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium
DK1625135T3 (da) Fondaparinux-natrium af höj renhed
IS7523A (is) Framleiðsla á súlfínýl asetamíði
DE60327447D1 (de) Pflaster
DE60326998D1 (de) Orale zubereitung
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
DK1357642T3 (da) Tilslutningssystem
FI20021531A0 (fi) Muurausmenetelmä
DK1558276T3 (da) Flavivirus-fusionsinhibitorer
EP1483963A4 (en) FALSE BAIT
DE50302653D1 (de) Zoomsystem
DE60237924D1 (de) Brillengelenk